Maxime Dely/LinkedIn

Mar 27, 2026, 18:02

Maxime Dely: Apheresis and the Limits of Standardization in Healthcare Quality

Maxime Dely, Sales and Application Specialist in Therapeutic Apheresis and Cell Therapy, shared a post on LinkedIn:

“Apheresis: how can we talk about quality when the patient is part of the process?

In hospitals, quality is built on solid foundations: validated protocols, controlled machines, and monitored indicators.

But in apheresis, one key element cannot be fully standardized: the patient.

In apheresis, the patient is not just the recipient of care.

They are part of the therapeutic process.

Same protocol, same team, same machine.

And yet, every session is different.

Tolerance, clinical condition, venous access, disease progression… variability is constant.

For hospital teams and blood bank organizations, this raises a fundamental question:

How do we ensure high quality in a living, adaptive process?

Of course, we rely on:

But real quality is also built through:

In apheresis, quality is not only about compliance.

It is a balance between safety, effectiveness, and clinical reality.

How far can we standardize without losing the quality of care?”

Maxime Dely: Apheresis and the Limits of Standardization in Healthcare Quality

Other posts featuring Maxime Dely on Hemostasis Today.

American Thrombosis and Hemostasis Network apheresis Health Hematology Hemostasis Hemostasis Today Maxime Dely Medicine

'

'

'

'

'

Hemostasis Today